University Hospital
Welcome,         Profile    Billing    Logout  
 20 Trials 
6 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
OBERT, Laurent
NCT05284357: Post Market Clinical Follow-up Study for Arthroplasty Shoulder System of FX Solutions at the Long Term

Recruiting
N/A
416
Europe, RoW
Shoulder Arthroplasty Surgery with HUMELOCK I & II® Anatomic Shoulder System, Shoulder Arthroplasty Surgery with HUMELOCK II® Reversible System, Shoulder Arthroplasty Surgery with HUMELOCK Reversed® Shoulder System, Shoulder Arthroplasty Surgery with EASYTECH® Anatomic Shoulder System, Shoulder Arthroplasty Surgery with EASYTECH® Reversed System (Primary intention), Shoulder Arthroplasty Surgery with EASYTECH® Reversible System (for revision only), Shoulder Arthroplasty Surgery with HUMERIS® Anatomic Shoulder System, Shoulder Arthroplasty Surgery with HUMERIS® Reversible Shoulder System
FX Solutions
Shoulder Disease, Shoulder Fractures, Shoulder Arthroplasty for Revision of Previous Treatment
10/22
10/22
Vuitton, Lucine
USTAP, NCT04496063: USTekinumab in Fistulising Perianal Crohn's Disease

Active, not recruiting
4
33
Europe
Ustekinumab, Stelara, Placebo
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives, Janssen, LP
Crohn's Disease
06/25
12/25
VERDICT, NCT04259138 / 2019-002485-12: Determination of the Optimal Treatment Target in Ulcerative Colitis

Active, not recruiting
4
672
Europe, Canada, US, RoW
Treatment Algorithm A, vedolizumab, Treatment Algorithm B, Treatment Algorithm C
Alimentiv Inc., Takeda Development Center Americas, Inc.
Colitis, Ulcerative
03/26
03/26
ABX464-105, NCT05507203: ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

Recruiting
3
612
Europe, Canada, US, RoW
ABX464, Obefazimod, Placebo
Abivax S.A.
Ulcerative Colitis
03/25
04/25
LUCENT-URGE, NCT05767021: A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis

Active, not recruiting
3
160
Europe, US, RoW
Mirikizumab, LY3074828
Eli Lilly and Company
Ulcerative Colitis, Ulcerative Colitis Chronic
08/24
09/25
ABTECT, NCT05535946: - Maintenance

Recruiting
3
1050
Europe, Canada, Japan, US, RoW
ABX464, Obefazimod, Placebo
Abivax S.A.
Ulcerative Colitis
01/26
01/30
Vanlemmens, C
No trials found
Toussirot, Eric
No trials found
Nobili, François
No trials found
ROBERT, Elise
No trials found
Béreau, Matthieu
No trials found
Perruche, Sylvain
No trials found
Vauchy, Charline
No trials found

Download Options